A Controlled Trial of a Single Dose of Azithromycin for the Treatment of Chlamydial Urethritis and Cervicitis
Open Access
- 24 September 1992
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (13) , 921-925
- https://doi.org/10.1056/nejm199209243271304
Abstract
Currently, there is no single-dose therapy that is effective in the treatment of urethral or endocervical infections with Chlamydia trachomatis. Azithromycin is a new azalide antibiotic that has substantial activity against C. trachomatis, is concentrated intracellularly, and has a long half-life in serum and tissue.Keywords
This publication has 17 references indexed in Scilit:
- Gynaecological tissue levels of azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin againstMycoplasma pneumoniae, Mycoplasma hominis andUreaplasma urealyticumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Compliance declines between clinic visitsArchives of internal medicine (1960), 1990
- The association between Chlamydia trachomatis and ectopic pregnancy. A matched-pair, case-control studyJAMA, 1990
- Treatment of Bramhamella catarrhalis infectionsJournal of Antimicrobial Chemotherapy, 1990
- Induction of β-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1990
- Chlamydial infectionsThe Journal of Pediatrics, 1989
- Chlamydia trachomatis infections in the United States. What are they costing us?Published by American Medical Association (AMA) ,1987
- Asymptomatic Chlamydia trachomatis Infections Among Sexually Active MenThe Journal of Infectious Diseases, 1986
- Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum.Journal of Clinical Investigation, 1977